Glucagon treatment for beta blocker overdose
Pro Research Analysisby 
Searched over 200M research papers
Glucagon Mechanism of Action in Beta Blocker Overdose
Glucagon is widely recognized as an effective treatment for beta blocker overdose because it increases heart rate and myocardial contractility, even when beta-adrenergic receptors are blocked. This is possible because glucagon acts through a different pathway, generating cyclic AMP (cAMP) in the heart independently of beta-adrenergic receptors, thereby bypassing the blockade and restoring cardiac function Peterson1984White1999Shepherd2006+1 MORE.
Clinical Efficacy and Use of Glucagon in Beta Blocker Toxicity
Glucagon is considered a first-line antidote for symptomatic beta blocker overdose, especially when patients present with bradycardia and hypotension that do not respond to standard treatments like atropine or isoproterenol Fell2011Shepherd2006. Clinical reports and case series have shown that glucagon administration can lead to increases in heart rate and blood pressure, although the absolute changes are often modest and their clinical significance may vary Peterson1984Senart2022Petersen2020. In both animal and human studies, glucagon consistently increases heart rate, but its effect on blood pressure and survival is less clear and may be transient .
Dosage, Administration, and Monitoring
The recommended dosing for severe beta blocker overdose is an initial intravenous loading dose of 50 micrograms/kg, followed by a continuous infusion of 1–15 mg per hour, titrated to the patient’s response . Both bolus and infusion methods have been used, with infusions potentially providing longer-lasting effects . Patients receiving glucagon should be closely monitored for side effects, including nausea, vomiting, hypokalemia, and hyperglycemia Peterson1984Senart2022Petersen2020.
Safety, Adverse Effects, and Limitations
While glucagon is generally safe, adverse effects such as nausea and vomiting are common, and hyperglycemia can also occur Peterson1984Senart2022Petersen2020. The high cost and limited availability of glucagon may limit its widespread use in some settings . Evidence supporting glucagon’s use is largely based on case reports, case series, and animal studies, with a lack of large, controlled human trials Overdose2023Bailey2003. Despite these limitations, glucagon remains a recommended therapy in clinical guidelines for beta blocker overdose .
Prehospital and Adjunctive Use
There is discussion about the potential for paramedics to administer intravenous glucagon in prehospital settings, given their experience with intramuscular glucagon and IV access skills. This could be beneficial in cases of symptomatic beta blocker overdose before hospital arrival .
Conclusion
Glucagon is a key treatment for beta blocker overdose, especially when standard therapies fail. It works by bypassing beta-adrenergic receptors to restore heart function. While its effects on heart rate are consistent, improvements in blood pressure and survival are less certain. Adverse effects are common but generally manageable. Despite limited high-quality evidence, glucagon remains a first-line antidote for beta blocker toxicity, with dosing and monitoring tailored to individual patient response.
Sources and full results
Most relevant research papers on this topic
Glucagon therapy for beta-blocker overdose.
Glucagon therapy effectively reverses cardiovascular depression in severe beta-blocker overdoses, with potential for future clinical acceptance due to its high cost and limited availability.
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Glucagon for the treatment of symptomatic beta blocker overdose.
Intravenous glucagon can support blood pressure in beta blocker overdose patients, as supported by six best evidence papers.
Cardiovascular and Adverse Effects of Glucagon for the Management of Suspected Beta Blocker Toxicity: a Case Series
Glucagon administration in patients with suspected beta blocker toxicity increased heart rate and systolic blood pressure, but had a small clinical significance, and few experienced adverse events.
PROTOCOL OF A SYSTEMATIC REVIEW AND METAANALYSIS OF CASE-SERIES AND CASE-REPORTS INVOLVING GLUCAGON IN BETA-BLOCKER OVERDOSE
This study aims to conduct a systematic review of glucagon outcomes in beta-blocker overdose cases, aiming to fill the gap in research on this topic.
DOI